Street Target Update on Marathon Oil Corporation (NYSE:MRO)

Share

The Company has 52-week high of $19.28 and 52-week low of $6.52.

The stock now has its Annual Dividend of $1.44 and an annual Dividend Yield of 2.83 Percent. That value represents a market adjusting for revenues that have been falling by -17.46 % on a quarterly year/year basis as of the company's last quarterly report. Marathon Petroleum Corporation had a return on equity of 5.74% and a net margin of 1.85%. Susquehanna assumed coverage on Marathon Oil Corporation in a report on Friday, November 18th.

Price Target is basically a projection of future price of a company's stock by the expert analysis of investment analysts or investment firms. 16 Analysts think that the Price Target for Marathon Petroleum Corporation (NYSE:MPC) might hit $62.72, however, the High Price Target and Low price Target are $72 and $48, respectively. The company's quarterly performance represents a passimistic momentum of -10.2 percent, with a decline of -2.44 percent in the stock price over the last one month. The consensus analyst PT for this stock has now been moved to $62.26.

Ex-Dividend Reminder: Applied Materials, j2 Global and Timken
The Company operates in four segments: Silicon Systems, Applied Global Services, Display, and Energy and Environmental Solutions. According to Zacks Investment Research , based on 9 analysts' forecasts, the consensus EPS forecast for the quarter is $0.66.

Marathon Petroleum Corporation (NYSE:MPC) remained flat at $50.96 on Wednesday. The firm's 50-day moving average price is $49.46 and its 200-day moving average price is $45.20. The company's previous year sales total was 12.83 Billion.

Marathon Oil Corporation (NYSE:MRO) went down -0.67% during trading on the United States exchange when it had traded 13.2M shares. A lower value may indicate larger traded value meaning more sell-side analysts may cover the company leading to a smaller chance shares are priced improperly.

During the quarter ended December 31, 2016, Marathon Petroleum total revenues and other income were $17.28 billion, which came in above $15.68 billion recorded at the end of Q4 FY15. The firm's revenue for the quarter was up 10.2% compared to the same quarter past year. As per the consensus estimate, the company's year-on-year revenue growth is expected to be at 32.66% during the period.

United Nations condemns North Korea missile launch
South Korea's finance ministry said it would act "swiftly and firmly" if financial markets reacted to the missile launch. North Korea fired the ballistic missile on a high arc into the sea early on Sunday, the first test of U.S.

Marathon Petroleum Corporation (NYSE:MPC) now has a consensus Price Target of $62.26. Majority ranked Overweight from the pool of analysts. The ex-dividend date is Tuesday, February 14th. One of the most common is the Price to Earnings Ratio or P/E Ratio.

Several hedge funds and other institutional investors have recently made changes to their positions in the company.

Marathon Oil Corporation closed its last trading session at $16.41 with the loss of -0.67%. The stock spiked 4.67% last month and is up 1.3 this year. Schroder Investment Management Group boosted its position in shares of Marathon Oil Corporation by 70.1% in the third quarter. The market capitalization arrived at market cap 2.70 billion. Scotiabank reiterated a "hold" rating and issued a $55.00 target price on shares of Marathon Petroleum Corporation in a report on Monday, February 6th. Evercore Wealth Management LLC now owns 7,701 shares of the company's stock worth $292,000 after buying an additional 193 shares during the last quarter. United Asset Strategies Inc. boosted its position in Marathon Petroleum Corporation by 12.6% in the second quarter. TIAA CREF Investment Management LLC now owns 3,387,403 shares of the company's stock valued at $53,555,000 after buying an additional 372,063 shares during the last quarter. Finally, Cornerstone Advisors Inc. raised its position in Marathon Petroleum Corporation by 23.8% in the third quarter. The share price is trading in a range of $50.27 - 51.15. The company's institutional ownership is monitored at 80 percent.

Earnings Prediction Review: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . IFM Investors Pty Ltd bought a new stake in shares of Alexion Pharmaceuticals during the fourth quarter valued at about $386,000.

It sells refined products to wholesale customers domestically and internationally, buyers on the spot market, its Speedway business segment, and to independent entrepreneurs operating Marathon retail outlets.

Share